Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol.
D000284:Administration, Oral; D000328:Adult; D000526:Alprenolol / Q000008:administration & dosage / Q000097:blood*; D001682:Biological Availability; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male
D000526:Alprenolol